A Multi-Center Study Assessing the Safety and Efficacy of the LEGION Medial Stabilized (MS) Insert in Patients Undergoing a Total Knee Arthroplasty (TKA)
A legfontosabb adatok
- Ki végzi
- Smith & Nephew, Inc.
- Hol
- Charleston, Madison, New York és Newton (Egyesült Államok)Mind a 4 helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 144 fő, tervezett
- Kezdés
- 2025. szept. 25.
- Várható befejezés
- 2036. dec.
- A vizsgálat típusa
- Megfigyeléses, 3 csoport
- A vizsgált kezelések
- Cemented CoCr
- Cemented Oxinium
- Cementless
- A regiszteradat frissítve
- 2026. augusztus 6.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults who need a first total knee replacement, or had one with the LEGION MS insert in the past 12 months. It studies how safe the insert is and how well it works over the long term.
- Életkor
- 18 to 80 years old
- Nem
- All sexes
- A betegség stádiuma
- Knee damage from wear-and-tear arthritis (osteoarthritis), arthritis after an injury, or inflammatory arthritis, needing a first total knee replacement.
- Korábbi kezelés
- New patients must need a first knee replacement. People who already had a first knee replacement with the study insert in the past 12 months can join if knee scores and X-rays were taken or can still be collected. People who had a redo knee replacement on the other knee, or a partial knee replacement, cannot join.
A részvétel fő kizáró okai
- Body Mass Index (BMI) of 40 or more
- Metal hardware already in the lower thigh bone or upper shin bone of the same leg
- Conditions that may harm the new knee, such as Paget's or Charcot's disease, lupus, uncontrolled diabetes or moderate to severe kidney problems
- Known allergy to parts of the study device
- Pregnant or breastfeeding, or able to get pregnant and not using highly effective birth control
A regiszter feltételei, szó szerint
Mind a 19 feltétel megnézéseKevesebb
Ki vehet részt
- A). Prospective Subjects: Subject needing primary Total Knee Arthroplasty (TKA) due to degenerative joint disease (primary diagnosis of osteoarthritis), post-traumatic arthritis or inflammatory arthritis; OR; B). Retro-prospective Subjects: Subject has undergone primary TKA using the investigational product in the past 12 months to repair degenerative joint disease, post-traumatic arthritis or inflammatory arthritis and all the following conditions have been met:; Pre-operative Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS JR) has been obtained; Post-operative radiographs have been obtained, or these can be collected prospectively in window per schedule of events; 12-month post-operative KOOS JR have been obtained, or these can be collected prospectively in window per schedule of events
- Subject's treating clinician has decided the study device is suitable for the subjects TKA procedure and the study device is used in line with the applicable Instructions For Use (IFU) (listed in section 6)
- Subject agrees to consent and follow the prospective study visit schedule up to 10 years post-surgery (as defined in the study protocol and informed consent form) by signing the Independent Review Board (IRB)/Independent Ethics Committee (IEC) approved consent form
- Subject is able to read, understand and communicate responses to Patient Reported Outcome Measure (PROM)
- Subject is 18-80 years old at the time of consent (inclusive)
Ki nem vehet részt
- Subject received revision TKA on the contralateral knee for a previously failed TKA, or Unicondylar Knee Arthroplasty (UKA)
- At the time of surgery, subject has one or more of the following arthroplasties that are not fully healed and/or well-functioning, in the opinion of the Investigator: Ipsilateral or contralateral primary total hip arthroplasty or hip resurfacing arthroplasty; contralateral primary TKA or UKA
- Subject is entered in another drug, biologic, or device study or has been treated with an investigational product in the past 30 days (30 days from operation/dosing)
- Women who are pregnant, nursing, or of child-bearing potential who are not utilizing highly effective birth control measures at the time of screening or the time of surgery
- Subjects who have participated previously in this clinical trial and who have been withdrawn
- Subject has a condition that may interfere with the TKA survival or outcome (e.g., Paget's or Charcot's disease, vascular insufficiency, lupus, muscular atrophy, uncontrolled diabetes, moderate to severe renal insufficiency or neuromuscular disease)
- Subject has a known allergy to one or more of the components of the study device
- Subject, in the opinion of the Investigator, has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study, ability to consent or complete the PROMs, including mental illness, drug or alcohol abuse
- In the opinion of the Investigator, or site staff, Subject is at risk for lost to follow-up, or failure to return for scheduled visits
- Subject has a Body Mass Index (BMI) ≥ 40 at pre-operative visit
- Subject has ipsilateral hip arthritis resulting in flexion contracture of the hip joint
- Any subject with hardware present in ipsilateral distal femur or proximal tibia
- Any subject that meets the definition of a Vulnerable Subject per ISO 14155 Section 3.55
- Subject does not meet the indication or is contraindicated for TKA according to specific Smith+Nephew LEGION Knee System IFU
A fő feltételek kérdésként
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 18 és 80 év között vagy?
Ez a vizsgálat jelenleg itt érhető el: Egyesült Államok.
- Medical University of South CarolinaCharleston, Egyesült ÁllamokContact: Erik HansenRésztvevőt keres
- University of WisconsinMadison, Egyesült ÁllamokContact: Brian NickelToborzás még nem indult
- New York University HospitalNew York, Egyesült ÁllamokContact: Ran SchwarzkopfRésztvevőt keres
- Newton-Wellesley HospitalNewton, Egyesült ÁllamokContact: Hayden BoxRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
The purpose of this study is to assess the long-term safety and performance of the LEGION Medial Stabilized insert and to generate clinical evidence to support and maintain product registration in global markets.
A vizsgálat 3 csoportja
- Cemented CoCr
LEGION MS with Cemented Tibia (JII) with LEGION CR non-porous (CoCr) Femoral component
- Cemented Oxinium
LEGION MS with Cemented Tibia (JII) with LEGION CR non-porous (Ox) Femoral component
- Cementless
LEGION MS with CONCELOC Tibia with LEGION CR porous (without HA) Femoral component
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- Kérdések a feltételekről
- Forrás: NCT07199738: ki vehet részt
- A regiszteradat frissítve
- 2026. augusztus 6.